BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 23249476)

  • 1. Noninvasive management of hemangioma and vascular malformation using intralesional bleomycin injection.
    Hassan Y; Osman AK; Altyeb A
    Ann Plast Surg; 2013 Jan; 70(1):70-3. PubMed ID: 23249476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional bleomycin injection in management of low flow vascular malformations in children.
    Mohan AT; Adams S; Adams K; Hudson DA
    J Plast Surg Hand Surg; 2015 Apr; 49(2):116-20. PubMed ID: 25204206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations.
    Muir T; Kirsten M; Fourie P; Dippenaar N; Ionescu GO
    Pediatr Surg Int; 2004 Jan; 19(12):766-73. PubMed ID: 14740248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin.
    Chen WL; Huang ZQ; Chai Q; Zhang DM; Wang YY; Wang HJ; Wang L; Fan S
    Int J Oral Maxillofac Surg; 2011 Jun; 40(6):572-6. PubMed ID: 21367582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations.
    Khandpur S; Sharma VK
    Dermatol Surg; 2010 Mar; 36(3):340-6. PubMed ID: 20100267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pingyangmycin sclerotherapy for infantile hemangiomas in oral and maxillofacial regions: an evaluation of 66 consecutive patients.
    Hou J; Wang M; Tang H; Wang Y; Huang H
    Int J Oral Maxillofac Surg; 2011 Nov; 40(11):1246-51. PubMed ID: 21893396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bleomycin therapy for lymphangioma].
    Kertész Z; Bălă G; Bancu S; Gozar H; Virgil G; Horváth E; Pávai Z
    Chirurgia (Bucur); 2011; 106(1):103-7. PubMed ID: 21523964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional bleomycin and sodium tetradecyl sulphate for haemangiomas and lymphangiomas.
    Harjai MM; Jha M
    Afr J Paediatr Surg; 2012; 9(1):47-51. PubMed ID: 22382104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations.
    Yang Y; Sun M; Ma Q; Cheng X; Ao J; Tian L; Wang L; Lei D
    J Vasc Surg; 2011 Jan; 53(1):150-5. PubMed ID: 20843632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary experience of percutaneous intralesional bleomycin injection for the treatment of orbital lymphatic-venous malformation refractory to surgery.
    Shen CY; Wu MC; Tyan YS; Ou CH; Chen TY; Wong HF
    Clin Radiol; 2012 Feb; 67(2):182-4. PubMed ID: 22018802
    [No Abstract]   [Full Text] [Related]  

  • 11. Intralesional radiofrequency in venous malformations.
    Garg S; Kumar S; Singh YB
    Br J Oral Maxillofac Surg; 2015 Mar; 53(3):213-6. PubMed ID: 25554592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation.
    Chaudry G; Guevara CJ; Rialon KL; Kerr C; Mulliken JB; Greene AK; Fishman SJ; Boyer D; Alomari AI
    Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1476-81. PubMed ID: 24938907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular treatment of slow-flow vascular malformations.
    Burrows PE
    Tech Vasc Interv Radiol; 2013 Mar; 16(1):12-21. PubMed ID: 23499128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralesional injection of Pingyangmycin for vascular malformations in oral and maxillofacial regions: an evaluation of 297 consecutive patients.
    Zheng JW; Yang XJ; Wang YA; He Y; Ye WM; Zhang ZY
    Oral Oncol; 2009 Oct; 45(10):872-6. PubMed ID: 19628423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic transmucosal direct puncture sclerotherapy for management of airway vascular malformations.
    Oomen KP; Paramasivam S; Waner M; Niimi Y; Fifi JT; Berenstein A; O TM
    Laryngoscope; 2016 Jan; 126(1):205-11. PubMed ID: 25970858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy.
    Shigematsu T; Sorscher M; Dier EC; Berenstein A
    J Neurointerv Surg; 2019 Jan; 11(1):57-61. PubMed ID: 29674482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional bleomycin injection treatment for vascular birthmarks: a 5-year experience at a single United Kingdom unit.
    Sainsbury DCG; Kessell G; Fall AJ; Hampton FJ; Guhan A; Muir T
    Plast Reconstr Surg; 2011 May; 127(5):2031-2044. PubMed ID: 21532430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium tetradecyl sulphate direct intralesional sclerotherapy of venous malformations of the vulva and vagina: report of five cases.
    Krokidis M; Venetucci P; Hatzidakis A; Iaccarino V
    Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S228-31. PubMed ID: 20559638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck.
    Mathur NN; Rana I; Bothra R; Dhawan R; Kathuria G; Pradhan T
    Int J Pediatr Otorhinolaryngol; 2005 Jan; 69(1):75-80. PubMed ID: 15627451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
    Spence J; Krings T; TerBrugge KG; Agid R
    Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.